The Somatic Genomic Landscape of Glioblastoma

Cited by (1,018)

Items 401–500 of 1,018

1. Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant IDH1
   Tali Mazor, Charles Chesnelong, Aleksandr Pankov, Llewellyn E. Jalbert, Chibo Hong, Josie L. Hayes, Ivan V. Smirnov, Roxanne E. Marshall, Camila Ferreira de Souza, Yaoqing Shen et al. · 2017 · Proceedings of the National Academy of Sciences
2. Chromatin run-on and sequencing maps the transcriptional regulatory landscape of glioblastoma multiforme
   Tinyi Chu, Edward J. Rice, Gregory T. Booth, H. Hans Salamanca, Zhong Wang, Leighton J. Core, Sharon L. Longo, Robert John Corona, Lawrence S. Chin, John T. Lis et al. · 2018 · Nature Genetics
3. A modular master regulator landscape controls cancer transcriptional identity
   Evan Paull, Àlvaro Aytés, Sunny J. Jones, Prem S. Subramaniam, Federico Manuel Giorgi, Eugene F. Douglass, Somnath Tagore, Brennan Chu, Alessandro Vasciaveo, Siyuan Zheng et al. · 2021 · Cell
4. mTORC2 in the center of cancer metabolic reprogramming
   Kenta Masui, Webster K. Cavenee, Paul S. Mischel · 2014 · Trends in Endocrinology and Metabolism
5. Pan-cancer characterisation of microRNA across cancer hallmarks reveals microRNA-mediated downregulation of tumour suppressors
   Andrew Dhawan, Jacob G. Scott, Adrian Llewellyn Harris, Francesca Meteora Buffa · 2018 · Nature Communications
6. Mechanisms and Consequences of Cancer Genome Instability: Lessons from Genome Sequencing Studies
   Jake June-Koo Lee, Yoon‐La Choi, Mijung Kwon, Peter J. Park · 2016 · Annual Review of Pathology Mechanisms of Disease
7. WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1
   I. Vassallo, P. Zinn, Marta Lai, Premnath Rajakannu, M. Hamou, M. Hegi · 2016 · Oncogene
8. Molecular Pathways: Deciphering Mechanisms of Resistance to Macrophage-Targeted Therapies
   Daniela F. Quail, Johanna A. Joyce · 2016 · Clinical Cancer Research
9. Glioblastoma under Siege: An Overview of Current Therapeutic Strategies
   Paolillo, Mayra, Boselli, Cinzia, Schinelli, Sergio · 2018 · Brain Sciences
10. Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma
    Lingxiang Wu, Wei Wu, Junxia Zhang, Zheng Zhao, Liangyu Li, Mengyan Zhu, Min Wu, Fan Wu, Fengqi Zhou, Yuxin Du et al. · 2022 · Cancer Discovery
11. Next-generation sequencing technologies: breaking the sound barrier of human genetics
    El Mustapha Bahassi, Peter J. Stambrook · 2014 · Mutagenesis
12. Prognostic quality of activating TERT promoter mutations in glioblastoma: interaction with the rs2853669 polymorphism and patient age at diagnosis
    Sabine Spiegl‐Kreinecker, Daniela Lötsch, Bahil Ghanim, Christine Pirker, Thomas T. Mohr, Magdalena Laaber, Serge Weis, A Olschowski, Gerald Webersinke, Josef Pichler et al. · 2015 · Neuro-Oncology
13. Cyclooxygenase-2 in glioblastoma multiforme
    Jiange Qiu, Zhi Shi, Jianxiong Jiang · 2016 · Drug Discovery Today
14. Cancer-mutation network and the number and specificity of driver mutations
    Jaime Iranzo, Iñigo Martincorena, Eugene V. Koonin · 2018 · Proceedings of the National Academy of Sciences
15. Telomere Maintenance Mechanisms in Cancer
    Tiago Bordeira Gaspar, Ana Sá, José Manuel Lopes, Manuel A. Sobrinho-Simões, Paula Soares, João Vinagre · 2018 · Genes
16. Dysregulation of Glutamate Transport Enhances Treg Function That Promotes VEGF Blockade Resistance in Glioblastoma
    Yu Long, Haipeng Tao, Aida Karachi, Adam Grippin, Linchun Jin, Yifan Chang, Wang Zhang, Kyle A. Dyson, Alicia Y. Hou, Na Meng et al. · 2019 · Cancer Research
17. YAP/TAZ Transcriptional Coactivators Create Therapeutic Vulnerability to Verteporfin in EGFR-mutant Glioblastoma
    Krishanthan Vigneswaran, Nathaniel Boyd, Se-Yeong Oh, Shoeb B. Lallani, Andrew B. Boucher, Stewart G. Neill, Jeffrey J. Olson, Renee D Read · 2020 · Clinical Cancer Research
18. Immune Checkpoint Targeted Therapy in Glioma: Status and Hopes
    Yangzhi Qi, Baohui Liu, Qian Sun, Xiaoxing Xiong, Qianxue Chen · 2020 · Frontiers in Immunology
19. SINGLE CELL DERIVED CLONAL ANALYSIS OF HUMAN GLIOBLASTOMA LINKS FUNCTIONAL AND GENOMIC HETEROGENEITY
    Peter B. Dirks, M. Meyer, Jüri Reimand, Xiaoyang Lan, Renee Head, X. Zhu, Michelle M. Kushida, Jane Bayani, Jessica C. Pressey, Anath Christopher Lionel et al. · 2014 · Neuro-Oncology
20. Attenuating the p53 Pathway in Human Cancers: Many Means to the Same End
    Amanda R. Wasylishen, Guillermina Lozano · 2016 · Cold Spring Harbor Perspectives in Medicine
21. Conditional Selection of Genomic Alterations Dictates Cancer Evolution and Oncogenic Dependencies
    Mina, Marco, Raynaud, Franck, Tavernari, Daniele, Battistello, Elena, Sungalee, Stephanie, Saghafinia, Sadegh, Laessle, Titouan, Sanchez-Vega, Francisco, Schultz, Nikolaus, Oricchio, Elisa et al. · 2017 · Cancer Cell
22. Berberine Induces Senescence of Human Glioblastoma Cells by Downregulating the EGFR–MEK–ERK Signaling Pathway
    Qiao Liu, Xiuhua Xu, Minnan Zhao, Zhao Wei, Xi Li, Xiyu Zhang, Zhaojian Liu, Yaoqin Gong, Changshun Shao · 2014 · Molecular Cancer Therapeutics
23. Metabolic Reprogramming in Brain Tumors
    Sriram Venneti, Craig B. Thompson · 2017 · Annual Review of Pathology Mechanisms of Disease
24. Glioblastoma vs temozolomide: can the red queen race be won?
    Anjali Arora, Kumaravel Somasundaram · 2019 · Cancer Biology & Therapy
25. Genomic alterations of ERBB receptors in cancer: clinical implications
    Rosalin Mishra, Ariella B. Hanker, Joan T. Garrett · 2017 · Oncotarget
26. Chromatin landscapes reveal developmentally encoded transcriptional states that define human glioblastoma
    Stephen C. Mack, Irtisha Singh, Xiuxing Wang, Rachel A. Hirsch, Quilian Wu, Rosie Villagomez, Jean A. Bernatchez, Zhe Zhu, Ryan C. Gimple, Leo J.Y. Kim et al. · 2019 · The Journal of Experimental Medicine
27. Genomic landscape of intracranial meningiomas
    Wenya Linda Bi, Malak Abedalthagafi, Peleg Moshe Horowitz, Pankaj Kumar Agarwalla, Yu Mei, Ayal Aaron Aizer, Ryan Brewster, Gavin P. Dunn, Ossama Al‐Mefty, Brian Michael Alexander et al. · 2016 · Journal of neurosurgery
28. Cohesin mutations in human cancer
    Victoria K. Hill, Jung-Sik Kim, Todd A. Waldman · 2016 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
29. Insertions and Deletions Target Lineage-Defining Genes in Human Cancers
    Marcin B. Imielinski, Guangwu Guo, Matthew M. Meyerson · 2017 · Cell
30. ATRX loss induces telomere dysfunction and necessitates induction of alternative lengthening of telomeres during human cell immortalization
    Fei Li, Zhong Deng, Ling Zhang, Caizhi Wu, Ying Jin, Inah Hwang, Olga V. Vladimirova, Libo Xu, Lynnie Yang, Bin Lu et al. · 2019 · The EMBO Journal
31. Anticancer Mechanism of Curcumin on Human Glioblastoma
    Shu Chyi Wong, Muhamad Noor Alfarizal Kamarudin, Rakesh Naidu · 2021 · Nutrients
32. Signaling pathways and therapeutic approaches in glioblastoma multiforme (Review)
    Marsel Khabibov, Айрат Гарифуллин, Yanis Boumber, Karam Khaddour, Manuel Fernandez, Firat Khamitov, Л. В. Халикова, Natalia S. Kuznetsova, Oleg Ivanovich Kit, Leonid V. Kharin · 2022 · International Journal of Oncology
33. CD44 interacts with HIF-2α to modulate the hypoxic phenotype of perinecrotic and perivascular glioma cells
    Johansson, Elinn, Grassi, Elisa S., Pantazopoulou, Vasiliki, Tong, Bei, Lindgren, David, Berg, Tracy J., Pietras, Elin J., Axelson, Håkan, Pietras, Alexander · 2017 · Cell Reports
34. Liquid Biopsy in Glioblastoma: Opportunities, Applications and Challenges
    Ander Saenz‐Antoñanzas, Jaione Auzmendi-Iriarte, Estefanía Carrasco‐García, Leire Moreno‐Cugnon, Irune Ruiz, Jorge Villanúa, Larraitz Egaña, David Otaegui, Nicolàs Samprón, Ander Matheu · 2019 · Cancers
35. Integrin α7 Is a Functional Marker and Potential Therapeutic Target in Glioblastoma
    Tobias L. Haas, Maria Rita Sciuto, Lidia Brunetto, Cecilia Valvo, Michele Signore, Micol Eleonora Fiori, Simona Di Martino, Stefano Giannetti, Liliana Morgante, Alessandra Boe et al. · 2017 · Cell stem cell
36. Characterization of gliomas: from morphology to molecules
    Sean P. Ferris, Jeffrey W. Hofmann, David A. Solomon, Arie Perry · 2017 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
37. The role of PTRF/Cavin1 as a biomarker in both glioma and serum exosomes
    Kai Huang, Chuan Fang, Kaikai Yi, Xing Liu, Hongzhao Qi, Yanli Tan, Junhu Zhou, Ying Li, Mingyang Liu, Yuqing Zhang et al. · 2018 · Theranostics
38. The Natural Flavonoid Galangin Elicits Apoptosis, Pyroptosis, and Autophagy in Glioblastoma
    Yang Kong, Zichao Feng, Anjing Chen, Qichao Qi, Mingzhi Han, Shuai Wang, Yulin Zhang, Xin Zhang, Ning Yang, Jiwei Wang et al. · 2019 · Frontiers in Oncology
39. CAR‐NK cells: the next wave of cellular therapy for cancer
    May Daher, Luciana Melo Garcia, Ye Li, Katayoun Rezvani · 2021 · Clinical & Translational Immunology
40. Causal Mechanistic Regulatory Network for Glioblastoma Deciphered Using Systems Genetics Network Analysis
    Christopher L. Plaisier, Sofie A. O’Brien, Brady M. Bernard, Sheila M. Reynolds, Zac Simon, Chad M. Toledo, Yu Ding, David J. Reiss, Patrick J. Paddison, Nitin S. Baliga · 2016 · Cell Systems
41. Immunotherapies for malignant glioma
    Vassiliki A. Boussiotis, Alain Charest · 2017 · Oncogene
42. CHASMplus Reveals the Scope of Somatic Missense Mutations Driving Human Cancers
    Collin J. Tokheim, Rachel Karchin · 2019 · Cell Systems
43. Experimental models and tools to tackle glioblastoma
    Faye L. Robertson, M. Marques-Torrejon, G. Morrison, S. Pollard · 2019 · Disease Models & Mechanisms
44. An integrative analysis of the age-associated multi-omic landscape across cancers
    Kasit Chatsirisupachai, Tom Lesluyes, Luminita Paraoan, Peter Van Loo, João Pedro de Magalhães · 2021 · Nature Communications
45. Fragmentation patterns and personalized sequencing of cell‐free DNA in urine and plasma of glioma patients
    Florent C. Mouliere, Christopher G. Smith, Katrin Heider, Jing Su, Ymke van der Pol, Mareike K. Thompson, James Morris, Jonathan C. M. Wan, Dineika Chandrananda, James Hadfield et al. · 2021 · EMBO Molecular Medicine
46. Elevated FOXG1 and SOX2 in glioblastoma enforces neural stem cell identity through transcriptional control of cell cycle and epigenetic regulators
    Harry J. C. J. Bulstrode, Ewan R Johnstone, María Ángeles Marqués‐Torrejón, Kirsty M. Ferguson, Raul Bardini Bressan, Carla Blin, Vivien Grant, Sabine Gogolok, Ester Gangoso, Sladjana Gagrica et al. · 2017 · Genes & Development
47. Pathology, Molecular Genetics, and Epigenetics of Diffuse Intrinsic Pontine Glioma
    Pawel Buczkowicz, Cynthia E Hawkins · 2015 · Frontiers in Oncology
48. Genomically amplified Akt3 activates DNA repair pathway and promotes glioma progression
    Kristen M. Turner, Youting Sun, Ping Ji, Kirsi Johanna Granberg, Brady M. Bernard, Limei Hu, David E. Cogdell, Xinhui Zhou, Olli P. Yli-Harja, Matti Nykter et al. · 2015 · Proceedings of the National Academy of Sciences
49. Network-based machine learning and graph theory algorithms for precision oncology
    Wei Zhang, JEREMY R. CHIEN, Jeongsik Yong, Rui Kuang · 2017 · npj Precision Oncology
50. A pilot precision medicine trial for children with diffuse intrinsic pontine glioma—PNOC003: A report from the Pacific Pediatric Neuro‐Oncology Consortium
    Sabine Mueller, Payal Jain, Winnie S. Liang, Lindsay Baker Kilburn, Cassie Kline, Nalin M. Gupta, Eshini Panditharatna, Suresh N. Magge, Bo Zhang, Yuankun Zhu et al. · 2019 · International Journal of Cancer
51. Poor prognosis associated with TERT gene alterations in meningioma is independent of the WHO classification: an individual patient data meta-analysis
    Christian Mirian, Anne Katrine Duun‐Henriksen, Tareq Adnan Juratli, Felix Sahm, Sabine Spiegl‐Kreinecker, Matthieu Peyre, Annamaria Biczok, Jörg‐Christian Tonn, Stéphane Goutagny, Luca Bertero et al. · 2020 · Journal of Neurology Neurosurgery & Psychiatry
52. Single-cell characterization of macrophages in glioblastoma reveals MARCO as a mesenchymal pro-tumor marker
    Andrew Chen, Robyn D. Gartrell, Junfei Zhao, Pavan S. Upadhyayula, Wenting Zhao, Jinzhou Yuan, Hanna E. Minns, Athanassios Dovas, Jeffrey N. Bruce, Anna Lasorella et al. · 2021 · Genome Medicine
53. The role of wild type RAS isoforms in cancer
    Zhou, Bingying, Der, Channing J., Cox, Adrienne D. · 2016 · Seminars in Cell & Developmental Biology
54. Genes associated with increased brain metastasis risk in non–small cell lung cancer: Comprehensive genomic profiling of 61 resected brain metastases versus primary non–small cell lung cancer (Guangdong Association Study of Thoracic Oncology 1036)
    Hongsheng Wang, Qiuxiang Ou, Delan Li, Tao Qin, Hua Bao, Xue Hou, Kaicheng Wang, Fang Wang, Qianqian Deng, Liang Jianzhong et al. · 2019 · Cancer
55. Targeting the peripheral neural-tumour microenvironment for cancer therapy
    Dan Yaniv, Brandi J. Mattson, Sébastien Talbot, Frederico O. Gleber‐Netto, Moran Amit · 2024 · Nature Reviews Drug Discovery
56. An AKT3-FOXG1-reelin network underlies defective migration in human focal malformations of cortical development
    Seung Tae Baek, Brett R. Copeland, Eun-Jin Yun, Seok‐Kyu Kwon, Alicia Guemez‐Gamboa, Ashleigh E. Schaffer, Sangwoo Kim, Hoon‐Chul Kang, Saera Song, Gary W. Mathern et al. · 2015 · Nature Medicine
57. Small extrachromosomal circular DNA (eccDNA): major functions in evolution and cancer
    Xiaoxuan Ling, Yali Han, Jinxue Meng, Bohuan Zhong, Jialong Chen, He Zhang, Jiheng Qin, Jing Pang, Linhua Liu · 2021 · Molecular Cancer
58. Malignant Glioma
    Linda M. Wang, Zachary K. Englander, Michael L. Miller, Jeffrey N. Bruce · 2023 · Advances in experimental medicine and biology
59. Targeting SOX2 as a Therapeutic Strategy in Glioblastoma
    Laura Garros-Regulez, Idoia García, Estefanía Carrasco‐García, Aquilino Lantero, Paula Aldaz, Leire Moreno‐Cugnon, Olatz Arrizabalaga, Jose Ignacio Undabeitia, Sergio Torres-Bayona, Jorge Villanúa et al. · 2016 · Frontiers in Oncology
60. Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients naive to antiangiogenic therapy
    Patrick Yung Wen, Jan Drappatz, John de Groot, Michael D. Prados, David A. Reardon, David Schiff, Marc Charles Chamberlain, Tom Mikkelsen, Annick Desjardins, Jaymes S. Holland et al. · 2017 · Neuro-Oncology
61. CDKN2A Alterations and Response to Immunotherapy in Solid Tumors
    Elio Adib, Amin H. Nassar, Elie W. Akl, Sarah Abou Alaiwi, Pier Vitale Nuzzo, Tarek H. Mouhieddine, Guru Sonpavde, Robert I. Haddad, Kent William Mouw, Marios Giannakis et al. · 2021 · Clinical Cancer Research
62. Glioblastoma Stem Cells Respond to Differentiation Cues but Fail to Undergo Commitment and Terminal Cell-Cycle Arrest
    Helena Carén, Stefan H. Stricker, Harry J. C. J. Bulstrode, Sladjana Gagrica, Ewan R Johnstone, Thomas E. Bartlett, Andrew Feber, Gareth A. Wilson, Andrew Erich Teschendorff, Paul Bertone et al. · 2015 · Stem Cell Reports
63. Telomerase promoter mutations in cancer: an emerging molecular biomarker?
    João Vinagre, Vasco Sá Pinto, Ricardo Celestino, M. Reis, Helena Pópulo, Paula Boaventura, Miguel Melo, Telmo A. Catarino, Jorge Pereira Lima, José Manuel Lopes et al. · 2014 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
64. Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors
    Marina N. Nikiforova, Abigail I. Wald, Melissa A. Melan, Somak Roy, Shan Zhong, Ronald L. Hamilton, Frank Scott Lieberman, Jan Drappatz, Nduka Amankulor, Ian F. Pollack et al. · 2015 · Neuro-Oncology
65. Olig2-Dependent Reciprocal Shift in PDGF and EGF Receptor Signaling Regulates Tumor Phenotype and Mitotic Growth in Malignant Glioma
    Fanghui Lu, Ying Chen, Chuntao Zhao, Haibo Wang, Danyang He, Lingli Xu, Jincheng Wang, Xuelian He, Yaqi Deng, Ellen E. Lu et al. · 2016 · Cancer Cell
66. Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo
    Nathaniel Boyd, Kiera D. Walker, Joshua S. Fried, James R. Hackney, Paul C. McDonald, Gloria A. Benavides, Raffaella Spina, Alessandra Audia, Sarah E. Scott, Catherine J. Libby et al. · 2017 · JCI Insight
67. Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective Study
    Stephen Joseph Bagley, Seyed Ali Nabavizadeh, Jazmine J. Mays, Jacob Edward Till, Jeffrey B. Ware, Scott C Levy, Whitney Sarchiapone, Jasmin Hussain, Timothy Prior, Samantha Guiry et al. · 2019 · Clinical Cancer Research
68. Disconnecting multicellular networks in brain tumours
    Varun Venkataramani, Matthias B. Schneider, Frank Anton Giordano, Thomas Kuner, Wolfgang Wick, Ulrich Herrlinger, Frank Winkler · 2022 · Nature reviews. Cancer
69. PRMT2 links histone H3R8 asymmetric dimethylation to oncogenic activation and tumorigenesis of glioblastoma
    Feng Dong, Qian Li, Chao Yang, Dawei Huo, Xing Wang, Chunbo Ai, Yu Kong, Xiaoyu Sun, Wen Wang, Yan Zhou et al. · 2018 · Nature Communications
70. Chloroquine combined with concurrent radiotherapy and temozolomide for newly diagnosed glioblastoma: a phase IB trial
    Inge Compter, Daniëlle B. P. Eekers, Ann Hoeben, Kasper M. A. Rouschop, Bart J.T. Reymen, Linda P.C.M. Ackermans, Jan Beckervordersantforth, Noël J.C. Bauer, Monique H. M. E. Anten, Pieter Wesseling et al. · 2020 · Autophagy
71. Preclinical Efficacy of the MDM2 Inhibitor RG7112 in <i>MDM2</i> -Amplified and <i>TP53</i> Wild-type Glioblastomas
    Verreault, Maite, Schmitt, Charlotte, Goldwirt, Lauriane, Pelton, Kristine, Haidar, Samer, Levasseur, Camille, Guehennec, Jeremy, Knoff, David, Labussière, Marianne, Marie, Yannick et al. · 2016 · Clinical Cancer Research
72. Dysregulated miR-671-5p / CDR1-AS / CDR1 / VSNL1 axis is involved in glioblastoma multiforme
    Davide Barbagallo, Angelo Giuseppe Condorelli, Marco Ragusa, Loredana Salito, Mariangela Sammito, Barbara Banelli, Rosario Caltabiano, Giuseppe Maria Vincenzo Barbagallo, Agata Zappalà, Rosalia Battaglia et al. · 2015 · Oncotarget
73. Non-invasive metabolic imaging of brain tumours in the era of precision medicine
    Michelle M. Kim, Abhijit Parolia, Mark P. Dunphy, Sriram Venneti · 2016 · Nature Reviews Clinical Oncology
74. Antibody–drug conjugates in glioblastoma therapy: the right drugs to the right cells
    Hui Kong Gan, Martin J. van den Bent, Andrew B. Lassman, David A. Reardon, Andrew Mark Scott · 2017 · Nature Reviews Clinical Oncology
75. High‐grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication—a comprehensive clinical, radiographic, pathologic, and genomic analysis
    Sean P. Ferris, José E. Velázquez Vega, Mariam Aboian, Julieann C. Lee, Jessica Van Ziffle, Courtney S. Onodera, James P. Grenert, Tara Saunders, Yunn-Yi Chen, Anu Banerjee et al. · 2019 · Brain Pathology
76. Epigenetic profiling for the molecular classification of metastatic brain tumors
    Javier I. J. Orozco, Theo Knijnenburg, Ayla O. Manughian-Peter, Matthew P. Salomon, Garni Barkhoudarian, John R. Jalas, James S. Wilmott, Parvinder Hothi, Xiaowen Wang, Yuki Takasumi et al. · 2018 · Nature Communications
77. Autologous Heat Shock Protein Peptide Vaccination for Newly Diagnosed Glioblastoma: Impact of Peripheral PD-L1 Expression on Response to Therapy
    Orin G. Bloch, Michael K. Lim, Michael E. Sughrue, Ricardo J. Komotar, John Matthew Abrahams, Donald M. O’Rourke, Anthony L. D’Ambrosio, Jeffrey N. Bruce, Andrew T. Parsa · 2017 · Clinical Cancer Research
78. Childhood Cancer: Occurrence, Treatment and Risk of Second Primary Malignancies
    Sebastian Zahnreich, Heinz Schmidberger · 2021 · Cancers
79. Circadian Regulator CLOCK Drives Immunosuppression in Glioblastoma
    Wenjing Xuan, Wen-Hao Hsu, Fatima Khan, Madeline Dunterman, Lizhi Pang, Derek Alan Wainwright, Atique U. Ahmed, Amy B. Heimberger, Maciej S. Lesniak, Peiwen Chen · 2022 · Cancer Immunology Research
80. Sema3C Promotes the Survival and Tumorigenicity of Glioma Stem Cells through Rac1 Activation
    Jianghong Man, Jocelyn D. Shoemake, Wenchao Zhou, Xiaoguang Fang, Qiulian Wu, Anthony E. Rizzo, Richard A. Prayson, Shideng Bao, Jeremy N. Rich, Jennifer S. Yu · 2014 · Cell Reports
81. Somatic POLE mutations cause an ultramutated giant cell high-grade glioma subtype with better prognosis
    Zeynep Erson-Omay, Ahmet Okay Çağlayan, Nikolaus D. Schultz, Nils Weinhold, Sacit Bulent Omay, Koray Özduman, Yavuz Köksal, Jie Li, Akdes Serin Harmancı, Victoria Elizabeth Clark et al. · 2015 · Neuro-Oncology
82. Epidermal growth factor receptor targeting and challenges in glioblastoma
    Amy Haseley Thorne, Ciro Zanca, Frank B. Furnari · 2016 · Neuro-Oncology
83. Molecular classification of gliomas
    Kenta Masui, Paul S. Mischel, Guido Reifenberger · 2016 · Handbook of clinical neurology
84. Radiolabeled Antibodies for Cancer Imaging and Therapy
    Sagun Parakh, Sze Ting Lee, Hui Kong Gan, Andrew Mark Scott · 2022 · Cancers
85. 5-Hydroxymethylcytosine localizes to enhancer elements and is associated with survival in glioblastoma patients
    Kevin C. Johnson, Eugene Andres Houseman, Jessica E. King, Katharine M. von Herrmann, Camilo E. Fadul, Brock C. Christensen · 2016 · Nature Communications
86. CICERO: a versatile method for detecting complex and diverse driver fusions using cancer RNA sequencing data
    Liqing Tian, Yongjin Li, Michael N. Edmonson, Xin Zhou, Scott Newman, Clay McLeod, Andrew Thrasher, Yu Liu, Bo Tang, Michael Rusch et al. · 2020 · Genome biology
87. Emerging themes in cohesin cancer biology
    Todd A. Waldman · 2020 · Nature reviews. Cancer
88. NF1 regulates mesenchymal glioblastoma plasticity and aggressiveness through the AP-1 transcription factor FOSL1
    Carolina Marques, Thomas Unterkircher, Paula Kroon, Barbara Oldrini, Annalisa Izzo, Yuliia Dramaretska, Roberto Ferrarese, Eva Kling, Oliver Schnell, Sven Nelander et al. · 2021 · eLife
89. The Cancer Genome Atlas Clinical Explorer: a web and mobile interface for identifying clinical–genomic driver associations
    HoJoon Lee, Jennifer Palm, Susan M. Grimes, Hanlee P. Ji · 2015 · Genome Medicine
90. Classification based on mutations ofTERTpromoter andIDHcharacterizes subtypes in grade II/III gliomas
    Pei Yang, Jinquan Cai, Wei Yan, Wei Zhang, Yinyan Wang, Baoshi Chen, Guilin Li, Shouwei Li, Chenxing Wu, Kun Yao et al. · 2016 · Neuro-Oncology
91. Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature‐on‐a‐Chip System Correlates with Tumor Heterogeneity and Subtypes
    Xiao, Yang, Kim, Dongjoo, Dura, Burak, Zhang, Kerou, Yan, Runchen, Li, Huamin, Han, Edward, Ip, Joshua, Zou, Pan, Liu, Jun et al. · 2019 · Advanced Science
92. Comprehensive molecular characterization of multifocal glioblastoma proves its monoclonal origin and reveals novel insights into clonal evolution and heterogeneity of glioblastomas
    Khalil Abou‐El‐Ardat, Michael Seifert, Kerstin Becker, Sophie Eisenreich, Matthias Lehmann, Karl Hackmann, Andreas Rump, Gerrit A. Meijer, Beatriz G. Carvalho, Achim Temme et al. · 2016 · Neuro-Oncology
93. Clinical Applications of Contrast-Enhanced Perfusion MRI Techniques in Gliomas: Recent Advances and Current Challenges
    Junfeng Zhang, Heng Liu, Haipeng Tong, Sumei Wang, Yizeng Yang, Gang Liu, Weiguo Zhang · 2017 · Contrast Media & Molecular Imaging
94. Interest of integrins targeting in glioblastoma according to tumor heterogeneity and cancer stem cell paradigm: an update
    Laure Malric, Sylvie Monferran, Julia Gilhodes, Sabrina Boyrie, Perrine Dahan, Nicolas Skuli, Julie Sesen, Thomas Filleron, Aline Kowalski‐Chauvel, Elizabeth Cohen‐Jonathan Moyal et al. · 2017 · Oncotarget
95. TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence
    Isabel Puig, Stephan P. Tenbaum, Irene Chicote, Oriol Arqués, Jordi Martínez‐Quintanilla, Estefania Cuesta-Borràs, Lorena Ramírez, Pilar Gonzalo, Atenea Soto, Susana Aguilar et al. · 2018 · Journal of Clinical Investigation
96. Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide
    Israel López-Valero, Cristina Sáiz-Ladera, Sofía Torres, Sonia Hernández‐Tiedra, Elena García-Taboada, Fátima Rodríguez-Fornés, Marina Barba‐Aliaga, David Dávila, Nélida Salvador, Manuel Guzmán et al. · 2018 · Biochemical Pharmacology
97. Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adults
    Jessica D. Schulte, Robin Arthur Buerki, Sarah Lapointe, Annette M. Molinaro, Yalan Zhang, Javier E. Villanueva-Meyer, Arie Perry, Joanna J. Phillips, Tarık Tihan, Andrew W. Bollen et al. · 2020 · Neuro-Oncology Advances
98. Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drug
    Junfeng Bi, Atif Ali Khan, Jun Tang, Aaron M. Armando, Sihan Wu, Wei Zhang, Ryan C. Gimple, Alex Reed, Hui Jing, Tomoyuki Koga et al. · 2021 · Cell Reports
99. CTLA-4 blockade induces a microglia-Th1 cell partnership that stimulates microglia phagocytosis and anti-tumor function in glioblastoma
    Dan Chen, Siva Karthik Varanasi, Toshiro Hara, Kacie A. Traina, Ming Hua Sun, Bryan McDonald, Yagmur Farsakoglu, Josh Clanton, Shihao Xu, Lizmarie Garcia-Rivera et al. · 2023 · Immunity
100. XGBoost Improves Classification of MGMT Promoter Methylation Status in IDH1 Wildtype Glioblastoma
     Nguyen Quoc Khanh Le, Duyen Thi Do, Fang-Ying Chiu, Edward Kien Yee Yapp, Hui‐Yuan Yeh, Cheng‐Yu Chen · 2020 · Journal of Personalized Medicine